High expression of KIBRA in low atypical protein kinase C-expressing gastric cancer correlates with lymphatic invasion and poor prognosis

Cancer Science

Volumn 104, Issue 2, 2013, Pages 259-265

  Yoshihama, Yohei ^a,b   Izumisawa, Yusuke ^a   Akimoto, Kazunori ^a,c   Satoh, Yoshinori ^a   Mizushima, Taichi ^d   Satoh, Kei ^a   Chida, Kazuhiro ^b   Takagawa, Ryo ^a   Akiyama, Hirotoshi ^a   Ichikawa, Yasushi ^a   Kunisaki, Chikara ^a   Inayama, Yoshiaki ^e   Endo, Itaru ^a   Nagashima, Yoji ^a   Ohno, Shigeo ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e Division of Anatomical and Surgical Pathology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KIBRA PROTEIN; PROTEIN; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; STOMACH CANCER; TIGHT JUNCTION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL COMMUNICATION; CELL POLARITY; CELLS, CULTURED; DISEASE-FREE SURVIVAL; DOGS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MADIN DARBY CANINE KIDNEY CELLS; MALE; MIDDLE AGED; PHOSPHOPROTEINS; PROGNOSIS; PROTEIN KINASE C; STOMACH NEOPLASMS; TIGHT JUNCTIONS;

EID: 84873728864     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12066     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-30.
2. Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Arch Pathol Lab Med 2004; 128: 765-70.
3. Faycal J, Bessaguet C, Nousbaum JB et al. Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995. Gastroenterol Clin Biol 2005; 29: 23-32.
4. Cunningham SC, Kamangar F, Kim MP et al. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg 2005; 9: 718-25.
5. Tsubono Y, Hisamichi S. Screening for gastric cancer in Japan. Gastric Cancer 2000; 3: 9-18.
6. Koizumi W, Narahara H, Hara T et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 2008; 9: 215-21.
7. Ajani JA. Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen. Cancer 2008; 113: 945-55.
8. Lee M, Vasioukhin V. Cell polarity and cancer-cell and tissue polarity as a non-canonical tumor suppressor. J Cell Sci 2008; 121: 1141-50.
9. Wodarz A, Nathke I. Cell polarity in development and cancer. Nat Cell Biol 2007; 9: 1016-24.
10. Tanos B, Rodriguez-Boulan E. The epithelial polarity program: machineries involved and their hijacking by cancer. Oncogene 2008; 27: 6939-57.
11. Martin-Belmonte F, Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 2012; 12: 23-38.
12. McCaffrey LM, Macara IG. Epithelial organization, cell polarity and tumorigenesis. Trends Cell Biol 2011; 21: 727-35.
13. Suzuki A, Ohno S. The PAR-aPKC system: lessons in polarity. J Cell Sci 2006; 119: 979-87.
14. Ohno S. Intercellular junctions and cellular polarity: the PAR-aPKC complex, a conserved core cassette playing fundamental roles in cell polarity. Curr Opin Cell Biol 2001; 13: 641-8.
15. Li Q, Wang JM, Liu C, Xiao BL, Lu JX, Zou SQ. Correlation of aPKCι and E-cadherin expression with invasion and prognosis of cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2008; 7: 70-5.
16. Kojima Y, Akimoto K, Nagashima Y et al. The overexpression and altered localization of the atypical protein kinase Cλ/ι in breast cancer correlates with the pathologic type of these tumors. Hum Pathol 2008; 39: 824-31.
17. Ishiguro H, Akimoto K, Nagashima Y et al. aPKCλ/ι promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6. Proc Natl Acad Sci USA 2009; 106: 16369-74.
18. Regala RP, Weems C, Jamieson L et al. Atypical protein kinase Cι is an oncogene in human non-small cell lung cancer. Cancer Res 2005; 65: 8905-11.
19. Eder AM, Sui X, Rosen DG et al. Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci USA 2005; 102: 12519-24.
20. Patel R, Win H, Desai S, Patel K, Matthews JA, Acevedo-Duncan M. Involvement of PKC-iota in glioma proliferation. Cell Prolif 2008; 41: 122-35.
21. Takagawa R, Akimoto K, Ichikawa Y et al. High expression of atypical protein kinase C λ/ι in gastric cancer as a prognostic factor for recurrence. Ann Surg Oncol 2010; 17: 81-8.
22. Namdarian B, Wong E, Galea R et al. Loss of APKC expression independently predicts tumor recurrence in superficial bladder cancers. Urol Oncol 2011 (in press).
23. Chalmers AD, Pambos M, Mason J, Lang S, Wylie C, Papalopulu N. aPKC, Crumbs3 and Lgl2 control apicobasal polarity in early vertebrate development. Development 2005; 132: 977-86.
24. Grifoni D, Garoia F, Bellosta P et al. aPKCζ cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia. Oncogene 2007; 26: 5960-5.
25. Suzuki A, Yamanaka T, Hirose T et al. Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J Cell Biol 2001; 152: 1183-96.
26. Buther K, Plaas C, Barnekow A, Kremerskothen J. KIBRA is a novel substrate for protein kinase Cζ. Biochem Biophys Res Commun 2004; 317: 703-7.
27. Yoshihama Y, Hirai T, Ohtsuka T, Chida K. KIBRA co-localizes with protein kinase Mζ (PKMζ) in the mouse hippocampus. Biosci Biotechnol Biochem 2009; 73: 147-51.
28. Yoshihama Y, Sasaki K, Horikoshi Y et al. KIBRA suppresses apical exocytosis through inhibition of aPKC kinase activity in epithelial cells. Curr Biol 2011; 21: 705-11.
29. Yu J, Zheng Y, Dong J et al. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell 2010; 18: 288-99.
30. Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell 2010; 18: 300-8.
31. Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H. The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell 2010; 18: 309-16.
32. Hill VK, Dunwell TL, Catchpoole D et al. Frequent epigenetic inactivation of KIBRA, an upstream member of the Salvador/Warts/Hippo (SWH) tumor suppressor network, is associated with specific genetic event in B-cell acute lymphocytic leukemia. Epigenetics 2011; 6: 326-32.
33. Hamilton SR, Aaltonen LA. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARCP Press, 2000.
34. Sobin LH, Wittekind CH. TNM: Classification of Malignant Tumours, 6th edn. New York: John Wiley & Sons, 2002.
35. Sato K, Watanabe T, Wang S et al. Numb controls E-cadherin endocytosis through p120 catenin with aPKC. Mol Biol Cell 2011; 22: 3103-19.
36. Suzuki A, Hirata M, Kamimura K et al. aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity. Curr Biol 2004; 14: 1425-35.
37. Kang W, Tong JH, Chan AW et al. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin Cancer Res 2011; 17: 2130-9.